nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamoxifen—ESR2—osteoporosis	0.145	0.438	CbGaD
Tamoxifen—CYP19A1—osteoporosis	0.0971	0.293	CbGaD
Tamoxifen—ESR1—osteoporosis	0.0893	0.27	CbGaD
Tamoxifen—ESRRA—Estradiol—osteoporosis	0.0599	0.123	CbGbCtD
Tamoxifen—ESR2—Estropipate—osteoporosis	0.0446	0.0919	CbGbCtD
Tamoxifen—EBP—Raloxifene—osteoporosis	0.0439	0.0905	CbGbCtD
Tamoxifen—ESR2—Raloxifene—osteoporosis	0.0298	0.0613	CbGbCtD
Tamoxifen—ESR2—Ethinyl Estradiol—osteoporosis	0.0288	0.0593	CbGbCtD
Tamoxifen—ESR1—Estropipate—osteoporosis	0.0229	0.0471	CbGbCtD
Tamoxifen—ESR2—Conjugated Estrogens—osteoporosis	0.0211	0.0435	CbGbCtD
Tamoxifen—SIGMAR1—Raloxifene—osteoporosis	0.0189	0.0389	CbGbCtD
Tamoxifen—ESR2—Estradiol—osteoporosis	0.0185	0.0382	CbGbCtD
Tamoxifen—ESR1—Raloxifene—osteoporosis	0.0153	0.0314	CbGbCtD
Tamoxifen—ABCB11—Ethinyl Estradiol—osteoporosis	0.0147	0.0303	CbGbCtD
Tamoxifen—ESR1—Ethinyl Estradiol—osteoporosis	0.0147	0.0303	CbGbCtD
Tamoxifen—CYP19A1—Raloxifene—osteoporosis	0.0124	0.0255	CbGbCtD
Tamoxifen—ESR1—Conjugated Estrogens—osteoporosis	0.0108	0.0223	CbGbCtD
Tamoxifen—CYP1B1—Estradiol—osteoporosis	0.00949	0.0196	CbGbCtD
Tamoxifen—ESR1—Estradiol—osteoporosis	0.00949	0.0196	CbGbCtD
Tamoxifen—ABCC2—Ethinyl Estradiol—osteoporosis	0.00775	0.016	CbGbCtD
Tamoxifen—ABCC2—Conjugated Estrogens—osteoporosis	0.00569	0.0117	CbGbCtD
Tamoxifen—CYP1A1—Cholecalciferol—osteoporosis	0.00517	0.0106	CbGbCtD
Tamoxifen—ABCG2—Conjugated Estrogens—osteoporosis	0.00514	0.0106	CbGbCtD
Tamoxifen—CYP2B6—Raloxifene—osteoporosis	0.0051	0.0105	CbGbCtD
Tamoxifen—CYP2B6—Ethinyl Estradiol—osteoporosis	0.00493	0.0101	CbGbCtD
Tamoxifen—ABCG2—Estradiol—osteoporosis	0.00451	0.0093	CbGbCtD
Tamoxifen—CYP1A2—Estropipate—osteoporosis	0.00448	0.00923	CbGbCtD
Tamoxifen—CYP1A1—Estradiol—osteoporosis	0.00417	0.00858	CbGbCtD
Tamoxifen—CYP2C9—Estropipate—osteoporosis	0.00404	0.00832	CbGbCtD
Tamoxifen—CYP2B6—Cholecalciferol—osteoporosis	0.00394	0.00811	CbGbCtD
Tamoxifen—CYP2C8—Raloxifene—osteoporosis	0.00386	0.00796	CbGbCtD
Tamoxifen—CYP2C8—Ethinyl Estradiol—osteoporosis	0.00373	0.00769	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Estradiol—osteoporosis	0.00333	0.00687	CbGbCtD
Tamoxifen—CYP3A7—Estradiol—osteoporosis	0.00333	0.00687	CbGbCtD
Tamoxifen—CYP2C8—Cholecalciferol—osteoporosis	0.00298	0.00614	CbGbCtD
Tamoxifen—ABCB1—Ethinyl Estradiol—osteoporosis	0.00253	0.0052	CbGbCtD
Tamoxifen—CYP2C19—Cholecalciferol—osteoporosis	0.0025	0.00515	CbGbCtD
Tamoxifen—CYP3A5—Estradiol—osteoporosis	0.0025	0.00515	CbGbCtD
Tamoxifen—CYP2C8—Estradiol—osteoporosis	0.0024	0.00495	CbGbCtD
Tamoxifen—CYP3A4—Estropipate—osteoporosis	0.00235	0.00484	CbGbCtD
Tamoxifen—CYP3A4—Calcitriol—osteoporosis	0.00235	0.00484	CbGbCtD
Tamoxifen—CYP1A2—Conjugated Estrogens—osteoporosis	0.00212	0.00437	CbGbCtD
Tamoxifen—CYP2C9—Cholecalciferol—osteoporosis	0.00208	0.00429	CbGbCtD
Tamoxifen—CYP2C19—Estradiol—osteoporosis	0.00202	0.00415	CbGbCtD
Tamoxifen—CYP2D6—Cholecalciferol—osteoporosis	0.0019	0.00392	CbGbCtD
Tamoxifen—CYP3A4—Ergocalciferol—osteoporosis	0.00188	0.00387	CbGbCtD
Tamoxifen—CYP1A2—Estradiol—osteoporosis	0.00186	0.00383	CbGbCtD
Tamoxifen—ABCB1—Conjugated Estrogens—osteoporosis	0.00185	0.00382	CbGbCtD
Tamoxifen—CYP2C9—Estradiol—osteoporosis	0.00168	0.00345	CbGbCtD
Tamoxifen—ABCB1—Estradiol—osteoporosis	0.00163	0.00335	CbGbCtD
Tamoxifen—CYP3A4—Raloxifene—osteoporosis	0.00157	0.00323	CbGbCtD
Tamoxifen—CYP3A4—Ethinyl Estradiol—osteoporosis	0.00151	0.00312	CbGbCtD
Tamoxifen—CYP3A4—Cholecalciferol—osteoporosis	0.00121	0.00249	CbGbCtD
Tamoxifen—CYP3A4—Conjugated Estrogens—osteoporosis	0.00111	0.00229	CbGbCtD
Tamoxifen—CYP3A4—Estradiol—osteoporosis	0.000975	0.00201	CbGbCtD
Tamoxifen—SIGMAR1—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.000637	1	CbGdCrCtD
Tamoxifen—Diethylstilbestrol—ESR2—osteoporosis	0.000412	0.173	CrCbGaD
Tamoxifen—Loperamide—POMC—osteoporosis	0.000399	0.167	CrCbGaD
Tamoxifen—Diethylstilbestrol—CYP19A1—osteoporosis	0.000276	0.116	CrCbGaD
Tamoxifen—Diethylstilbestrol—ESR1—osteoporosis	0.000254	0.106	CrCbGaD
Tamoxifen—Ospemifene—ESR1—osteoporosis	0.000247	0.103	CrCbGaD
Tamoxifen—Toremifene—ESR1—osteoporosis	0.000201	0.0844	CrCbGaD
Tamoxifen—Clomifene—CYP19A1—osteoporosis	0.000189	0.0792	CrCbGaD
Tamoxifen—Clomifene—ESR1—osteoporosis	0.000174	0.0729	CrCbGaD
Tamoxifen—Levomethadyl Acetate—CYP19A1—osteoporosis	0.000148	0.0619	CrCbGaD
Tamoxifen—Methadone—CYP19A1—osteoporosis	8.66e-05	0.0363	CrCbGaD
Tamoxifen—Back pain—Conjugated Estrogens—osteoporosis	6.61e-05	0.000533	CcSEcCtD
Tamoxifen—Urticaria—Alendronate—osteoporosis	6.6e-05	0.000533	CcSEcCtD
Tamoxifen—Anxiety—Pamidronate—osteoporosis	6.59e-05	0.000532	CcSEcCtD
Tamoxifen—Abdominal pain—Alendronate—osteoporosis	6.57e-05	0.00053	CcSEcCtD
Tamoxifen—Muscle spasms—Conjugated Estrogens—osteoporosis	6.57e-05	0.00053	CcSEcCtD
Tamoxifen—Sinusitis—Estradiol—osteoporosis	6.57e-05	0.00053	CcSEcCtD
Tamoxifen—Anaemia—Zoledronate—osteoporosis	6.56e-05	0.000529	CcSEcCtD
Tamoxifen—Discomfort—Pamidronate—osteoporosis	6.53e-05	0.000527	CcSEcCtD
Tamoxifen—Angioedema—Zoledronate—osteoporosis	6.48e-05	0.000523	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Calcitriol—osteoporosis	6.48e-05	0.000523	CcSEcCtD
Tamoxifen—Abdominal pain—Raloxifene—osteoporosis	6.46e-05	0.000522	CcSEcCtD
Tamoxifen—Urticaria—Ibandronate—osteoporosis	6.43e-05	0.000519	CcSEcCtD
Tamoxifen—Abdominal pain—Ibandronate—osteoporosis	6.4e-05	0.000516	CcSEcCtD
Tamoxifen—Leukopenia—Zoledronate—osteoporosis	6.35e-05	0.000513	CcSEcCtD
Tamoxifen—Oedema—Pamidronate—osteoporosis	6.34e-05	0.000512	CcSEcCtD
Tamoxifen—Haemoglobin—Estradiol—osteoporosis	6.31e-05	0.00051	CcSEcCtD
Tamoxifen—Infection—Pamidronate—osteoporosis	6.3e-05	0.000508	CcSEcCtD
Tamoxifen—Urticaria—Calcitriol—osteoporosis	6.29e-05	0.000508	CcSEcCtD
Tamoxifen—Haemorrhage—Estradiol—osteoporosis	6.28e-05	0.000507	CcSEcCtD
Tamoxifen—Hepatitis—Estradiol—osteoporosis	6.28e-05	0.000507	CcSEcCtD
Tamoxifen—Abdominal pain—Calcitriol—osteoporosis	6.26e-05	0.000506	CcSEcCtD
Tamoxifen—Hypoaesthesia—Estradiol—osteoporosis	6.25e-05	0.000505	CcSEcCtD
Tamoxifen—Angioedema—Conjugated Estrogens—osteoporosis	6.24e-05	0.000504	CcSEcCtD
Tamoxifen—Pharyngitis—Estradiol—osteoporosis	6.23e-05	0.000503	CcSEcCtD
Tamoxifen—Hypersensitivity—Estropipate—osteoporosis	6.22e-05	0.000502	CcSEcCtD
Tamoxifen—Thrombocytopenia—Pamidronate—osteoporosis	6.21e-05	0.000501	CcSEcCtD
Tamoxifen—Vomiting—Etidronic acid—osteoporosis	6.2e-05	0.000501	CcSEcCtD
Tamoxifen—Cough—Zoledronate—osteoporosis	6.19e-05	0.0005	CcSEcCtD
Tamoxifen—Oedema peripheral—Estradiol—osteoporosis	6.19e-05	0.0005	CcSEcCtD
Tamoxifen—Rash—Etidronic acid—osteoporosis	6.15e-05	0.000496	CcSEcCtD
Tamoxifen—Dermatitis—Etidronic acid—osteoporosis	6.15e-05	0.000496	CcSEcCtD
Tamoxifen—Hyperhidrosis—Pamidronate—osteoporosis	6.13e-05	0.000495	CcSEcCtD
Tamoxifen—Hypertension—Zoledronate—osteoporosis	6.13e-05	0.000495	CcSEcCtD
Tamoxifen—Hypersensitivity—Alendronate—osteoporosis	6.12e-05	0.000494	CcSEcCtD
Tamoxifen—Headache—Etidronic acid—osteoporosis	6.11e-05	0.000493	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Risedronate—osteoporosis	6.08e-05	0.00049	CcSEcCtD
Tamoxifen—Asthenia—Estropipate—osteoporosis	6.06e-05	0.000489	CcSEcCtD
Tamoxifen—Visual impairment—Estradiol—osteoporosis	6.05e-05	0.000489	CcSEcCtD
Tamoxifen—Anorexia—Pamidronate—osteoporosis	6.04e-05	0.000488	CcSEcCtD
Tamoxifen—Arthralgia—Zoledronate—osteoporosis	6.04e-05	0.000488	CcSEcCtD
Tamoxifen—Chest pain—Zoledronate—osteoporosis	6.04e-05	0.000488	CcSEcCtD
Tamoxifen—Myalgia—Zoledronate—osteoporosis	6.04e-05	0.000488	CcSEcCtD
Tamoxifen—Insomnia—Risedronate—osteoporosis	6.03e-05	0.000487	CcSEcCtD
Tamoxifen—Anxiety—Zoledronate—osteoporosis	6.02e-05	0.000486	CcSEcCtD
Tamoxifen—Paraesthesia—Risedronate—osteoporosis	5.99e-05	0.000483	CcSEcCtD
Tamoxifen—Pruritus—Estropipate—osteoporosis	5.97e-05	0.000482	CcSEcCtD
Tamoxifen—Discomfort—Zoledronate—osteoporosis	5.97e-05	0.000482	CcSEcCtD
Tamoxifen—Asthenia—Alendronate—osteoporosis	5.96e-05	0.000481	CcSEcCtD
Tamoxifen—Hypersensitivity—Ibandronate—osteoporosis	5.96e-05	0.000481	CcSEcCtD
Tamoxifen—Cough—Conjugated Estrogens—osteoporosis	5.96e-05	0.000481	CcSEcCtD
Tamoxifen—Dyspnoea—Risedronate—osteoporosis	5.95e-05	0.00048	CcSEcCtD
Tamoxifen—Erythema multiforme—Estradiol—osteoporosis	5.94e-05	0.000479	CcSEcCtD
Tamoxifen—Dry mouth—Zoledronate—osteoporosis	5.91e-05	0.000477	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	5.91e-05	0.000477	CcSEcCtD
Tamoxifen—Fatigue—Ethinyl Estradiol—osteoporosis	5.9e-05	0.000476	CcSEcCtD
Tamoxifen—Pruritus—Alendronate—osteoporosis	5.88e-05	0.000475	CcSEcCtD
Tamoxifen—Dyspepsia—Risedronate—osteoporosis	5.87e-05	0.000474	CcSEcCtD
Tamoxifen—Constipation—Ethinyl Estradiol—osteoporosis	5.85e-05	0.000472	CcSEcCtD
Tamoxifen—Hypersensitivity—Calcitriol—osteoporosis	5.84e-05	0.000471	CcSEcCtD
Tamoxifen—Flushing—Estradiol—osteoporosis	5.83e-05	0.000471	CcSEcCtD
Tamoxifen—Chest pain—Conjugated Estrogens—osteoporosis	5.82e-05	0.00047	CcSEcCtD
Tamoxifen—Myalgia—Conjugated Estrogens—osteoporosis	5.82e-05	0.00047	CcSEcCtD
Tamoxifen—Arthralgia—Conjugated Estrogens—osteoporosis	5.82e-05	0.00047	CcSEcCtD
Tamoxifen—Asthenia—Ibandronate—osteoporosis	5.81e-05	0.000469	CcSEcCtD
Tamoxifen—Anxiety—Conjugated Estrogens—osteoporosis	5.8e-05	0.000468	CcSEcCtD
Tamoxifen—Nausea—Etidronic acid—osteoporosis	5.79e-05	0.000468	CcSEcCtD
Tamoxifen—Oedema—Zoledronate—osteoporosis	5.79e-05	0.000467	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Pamidronate—osteoporosis	5.78e-05	0.000466	CcSEcCtD
Tamoxifen—Diarrhoea—Estropipate—osteoporosis	5.77e-05	0.000466	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Risedronate—osteoporosis	5.76e-05	0.000465	CcSEcCtD
Tamoxifen—Infection—Zoledronate—osteoporosis	5.75e-05	0.000464	CcSEcCtD
Tamoxifen—Fatigue—Risedronate—osteoporosis	5.75e-05	0.000464	CcSEcCtD
Tamoxifen—Insomnia—Pamidronate—osteoporosis	5.73e-05	0.000463	CcSEcCtD
Tamoxifen—Pruritus—Ibandronate—osteoporosis	5.73e-05	0.000462	CcSEcCtD
Tamoxifen—Pain—Risedronate—osteoporosis	5.7e-05	0.00046	CcSEcCtD
Tamoxifen—Constipation—Risedronate—osteoporosis	5.7e-05	0.00046	CcSEcCtD
Tamoxifen—Paraesthesia—Pamidronate—osteoporosis	5.69e-05	0.00046	CcSEcCtD
Tamoxifen—Diarrhoea—Alendronate—osteoporosis	5.69e-05	0.000459	CcSEcCtD
Tamoxifen—Asthenia—Calcitriol—osteoporosis	5.68e-05	0.000459	CcSEcCtD
Tamoxifen—Thrombocytopenia—Zoledronate—osteoporosis	5.67e-05	0.000458	CcSEcCtD
Tamoxifen—Dyspnoea—Pamidronate—osteoporosis	5.65e-05	0.000456	CcSEcCtD
Tamoxifen—Pruritus—Calcitriol—osteoporosis	5.6e-05	0.000452	CcSEcCtD
Tamoxifen—Hyperhidrosis—Zoledronate—osteoporosis	5.6e-05	0.000452	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	5.59e-05	0.000452	CcSEcCtD
Tamoxifen—Diarrhoea—Raloxifene—osteoporosis	5.59e-05	0.000451	CcSEcCtD
Tamoxifen—Dyspepsia—Pamidronate—osteoporosis	5.58e-05	0.00045	CcSEcCtD
Tamoxifen—Dizziness—Estropipate—osteoporosis	5.58e-05	0.00045	CcSEcCtD
Tamoxifen—Oedema—Conjugated Estrogens—osteoporosis	5.58e-05	0.00045	CcSEcCtD
Tamoxifen—Alopecia—Estradiol—osteoporosis	5.55e-05	0.000448	CcSEcCtD
Tamoxifen—Infection—Conjugated Estrogens—osteoporosis	5.54e-05	0.000447	CcSEcCtD
Tamoxifen—Diarrhoea—Ibandronate—osteoporosis	5.54e-05	0.000447	CcSEcCtD
Tamoxifen—Anorexia—Zoledronate—osteoporosis	5.52e-05	0.000446	CcSEcCtD
Tamoxifen—Decreased appetite—Pamidronate—osteoporosis	5.51e-05	0.000445	CcSEcCtD
Tamoxifen—Dizziness—Alendronate—osteoporosis	5.5e-05	0.000444	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Pamidronate—osteoporosis	5.47e-05	0.000442	CcSEcCtD
Tamoxifen—Erythema—Estradiol—osteoporosis	5.47e-05	0.000441	CcSEcCtD
Tamoxifen—Fatigue—Pamidronate—osteoporosis	5.47e-05	0.000441	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Risedronate—osteoporosis	5.45e-05	0.00044	CcSEcCtD
Tamoxifen—Urticaria—Ethinyl Estradiol—osteoporosis	5.43e-05	0.000439	CcSEcCtD
Tamoxifen—Constipation—Pamidronate—osteoporosis	5.42e-05	0.000438	CcSEcCtD
Tamoxifen—Pain—Pamidronate—osteoporosis	5.42e-05	0.000438	CcSEcCtD
Tamoxifen—Diarrhoea—Calcitriol—osteoporosis	5.42e-05	0.000438	CcSEcCtD
Tamoxifen—Abdominal pain—Ethinyl Estradiol—osteoporosis	5.41e-05	0.000437	CcSEcCtD
Tamoxifen—Dizziness—Raloxifene—osteoporosis	5.41e-05	0.000436	CcSEcCtD
Tamoxifen—Hyperhidrosis—Conjugated Estrogens—osteoporosis	5.39e-05	0.000435	CcSEcCtD
Tamoxifen—Vomiting—Estropipate—osteoporosis	5.37e-05	0.000433	CcSEcCtD
Tamoxifen—Dysgeusia—Estradiol—osteoporosis	5.36e-05	0.000432	CcSEcCtD
Tamoxifen—Dizziness—Ibandronate—osteoporosis	5.35e-05	0.000432	CcSEcCtD
Tamoxifen—Rash—Estropipate—osteoporosis	5.32e-05	0.00043	CcSEcCtD
Tamoxifen—Dermatitis—Estropipate—osteoporosis	5.32e-05	0.000429	CcSEcCtD
Tamoxifen—Anorexia—Conjugated Estrogens—osteoporosis	5.32e-05	0.000429	CcSEcCtD
Tamoxifen—Urticaria—Risedronate—osteoporosis	5.3e-05	0.000428	CcSEcCtD
Tamoxifen—Back pain—Estradiol—osteoporosis	5.29e-05	0.000427	CcSEcCtD
Tamoxifen—Headache—Estropipate—osteoporosis	5.29e-05	0.000427	CcSEcCtD
Tamoxifen—Vomiting—Alendronate—osteoporosis	5.29e-05	0.000427	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Zoledronate—osteoporosis	5.28e-05	0.000426	CcSEcCtD
Tamoxifen—Abdominal pain—Risedronate—osteoporosis	5.27e-05	0.000426	CcSEcCtD
Tamoxifen—Muscle spasms—Estradiol—osteoporosis	5.26e-05	0.000424	CcSEcCtD
Tamoxifen—Rash—Alendronate—osteoporosis	5.24e-05	0.000423	CcSEcCtD
Tamoxifen—Insomnia—Zoledronate—osteoporosis	5.24e-05	0.000423	CcSEcCtD
Tamoxifen—Dermatitis—Alendronate—osteoporosis	5.24e-05	0.000423	CcSEcCtD
Tamoxifen—Headache—Alendronate—osteoporosis	5.21e-05	0.00042	CcSEcCtD
Tamoxifen—Paraesthesia—Zoledronate—osteoporosis	5.2e-05	0.00042	CcSEcCtD
Tamoxifen—Vomiting—Raloxifene—osteoporosis	5.2e-05	0.00042	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Pamidronate—osteoporosis	5.18e-05	0.000418	CcSEcCtD
Tamoxifen—Dyspnoea—Zoledronate—osteoporosis	5.16e-05	0.000417	CcSEcCtD
Tamoxifen—Rash—Raloxifene—osteoporosis	5.15e-05	0.000416	CcSEcCtD
Tamoxifen—Dermatitis—Raloxifene—osteoporosis	5.15e-05	0.000416	CcSEcCtD
Tamoxifen—Vomiting—Ibandronate—osteoporosis	5.15e-05	0.000415	CcSEcCtD
Tamoxifen—Headache—Raloxifene—osteoporosis	5.12e-05	0.000413	CcSEcCtD
Tamoxifen—Rash—Ibandronate—osteoporosis	5.1e-05	0.000412	CcSEcCtD
Tamoxifen—Dermatitis—Ibandronate—osteoporosis	5.1e-05	0.000412	CcSEcCtD
Tamoxifen—Dyspepsia—Zoledronate—osteoporosis	5.1e-05	0.000411	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	5.08e-05	0.00041	CcSEcCtD
Tamoxifen—Headache—Ibandronate—osteoporosis	5.07e-05	0.000409	CcSEcCtD
Tamoxifen—Insomnia—Conjugated Estrogens—osteoporosis	5.04e-05	0.000407	CcSEcCtD
Tamoxifen—Hypersensitivity—Ethinyl Estradiol—osteoporosis	5.04e-05	0.000407	CcSEcCtD
Tamoxifen—Vomiting—Calcitriol—osteoporosis	5.04e-05	0.000407	CcSEcCtD
Tamoxifen—Decreased appetite—Zoledronate—osteoporosis	5.03e-05	0.000406	CcSEcCtD
Tamoxifen—Nausea—Estropipate—osteoporosis	5.01e-05	0.000405	CcSEcCtD
Tamoxifen—Abdominal pain—Pamidronate—osteoporosis	5.01e-05	0.000405	CcSEcCtD
Tamoxifen—Paraesthesia—Conjugated Estrogens—osteoporosis	5.01e-05	0.000404	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Zoledronate—osteoporosis	5e-05	0.000404	CcSEcCtD
Tamoxifen—Angioedema—Estradiol—osteoporosis	5e-05	0.000403	CcSEcCtD
Tamoxifen—Rash—Calcitriol—osteoporosis	5e-05	0.000403	CcSEcCtD
Tamoxifen—Fatigue—Zoledronate—osteoporosis	4.99e-05	0.000403	CcSEcCtD
Tamoxifen—Dermatitis—Calcitriol—osteoporosis	4.99e-05	0.000403	CcSEcCtD
Tamoxifen—Dyspnoea—Conjugated Estrogens—osteoporosis	4.97e-05	0.000401	CcSEcCtD
Tamoxifen—Headache—Calcitriol—osteoporosis	4.96e-05	0.000401	CcSEcCtD
Tamoxifen—Pain—Zoledronate—osteoporosis	4.95e-05	0.0004	CcSEcCtD
Tamoxifen—Constipation—Zoledronate—osteoporosis	4.95e-05	0.0004	CcSEcCtD
Tamoxifen—Nausea—Alendronate—osteoporosis	4.94e-05	0.000399	CcSEcCtD
Tamoxifen—Hypersensitivity—Risedronate—osteoporosis	4.91e-05	0.000397	CcSEcCtD
Tamoxifen—Dyspepsia—Conjugated Estrogens—osteoporosis	4.91e-05	0.000396	CcSEcCtD
Tamoxifen—Asthenia—Ethinyl Estradiol—osteoporosis	4.91e-05	0.000396	CcSEcCtD
Tamoxifen—Nausea—Raloxifene—osteoporosis	4.86e-05	0.000392	CcSEcCtD
Tamoxifen—Decreased appetite—Conjugated Estrogens—osteoporosis	4.85e-05	0.000391	CcSEcCtD
Tamoxifen—Pruritus—Ethinyl Estradiol—osteoporosis	4.84e-05	0.000391	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	4.81e-05	0.000389	CcSEcCtD
Tamoxifen—Fatigue—Conjugated Estrogens—osteoporosis	4.81e-05	0.000388	CcSEcCtD
Tamoxifen—Nausea—Ibandronate—osteoporosis	4.81e-05	0.000388	CcSEcCtD
Tamoxifen—Asthenia—Risedronate—osteoporosis	4.79e-05	0.000386	CcSEcCtD
Tamoxifen—Cough—Estradiol—osteoporosis	4.77e-05	0.000385	CcSEcCtD
Tamoxifen—Pain—Conjugated Estrogens—osteoporosis	4.77e-05	0.000385	CcSEcCtD
Tamoxifen—Constipation—Conjugated Estrogens—osteoporosis	4.77e-05	0.000385	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Zoledronate—osteoporosis	4.74e-05	0.000382	CcSEcCtD
Tamoxifen—Hypertension—Estradiol—osteoporosis	4.72e-05	0.000381	CcSEcCtD
Tamoxifen—Pruritus—Risedronate—osteoporosis	4.72e-05	0.000381	CcSEcCtD
Tamoxifen—Nausea—Calcitriol—osteoporosis	4.71e-05	0.00038	CcSEcCtD
Tamoxifen—Diarrhoea—Ethinyl Estradiol—osteoporosis	4.68e-05	0.000378	CcSEcCtD
Tamoxifen—Hypersensitivity—Pamidronate—osteoporosis	4.67e-05	0.000377	CcSEcCtD
Tamoxifen—Arthralgia—Estradiol—osteoporosis	4.66e-05	0.000376	CcSEcCtD
Tamoxifen—Myalgia—Estradiol—osteoporosis	4.66e-05	0.000376	CcSEcCtD
Tamoxifen—Chest pain—Estradiol—osteoporosis	4.66e-05	0.000376	CcSEcCtD
Tamoxifen—Anxiety—Estradiol—osteoporosis	4.64e-05	0.000374	CcSEcCtD
Tamoxifen—Urticaria—Zoledronate—osteoporosis	4.6e-05	0.000371	CcSEcCtD
Tamoxifen—Discomfort—Estradiol—osteoporosis	4.6e-05	0.000371	CcSEcCtD
Tamoxifen—Abdominal pain—Zoledronate—osteoporosis	4.58e-05	0.00037	CcSEcCtD
Tamoxifen—Diarrhoea—Risedronate—osteoporosis	4.56e-05	0.000368	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	4.56e-05	0.000368	CcSEcCtD
Tamoxifen—Dry mouth—Estradiol—osteoporosis	4.55e-05	0.000368	CcSEcCtD
Tamoxifen—Asthenia—Pamidronate—osteoporosis	4.55e-05	0.000367	CcSEcCtD
Tamoxifen—Dizziness—Ethinyl Estradiol—osteoporosis	4.52e-05	0.000365	CcSEcCtD
Tamoxifen—Pruritus—Pamidronate—osteoporosis	4.49e-05	0.000362	CcSEcCtD
Tamoxifen—Oedema—Estradiol—osteoporosis	4.46e-05	0.00036	CcSEcCtD
Tamoxifen—Infection—Estradiol—osteoporosis	4.43e-05	0.000358	CcSEcCtD
Tamoxifen—Urticaria—Conjugated Estrogens—osteoporosis	4.43e-05	0.000358	CcSEcCtD
Tamoxifen—Dizziness—Risedronate—osteoporosis	4.41e-05	0.000356	CcSEcCtD
Tamoxifen—Abdominal pain—Conjugated Estrogens—osteoporosis	4.41e-05	0.000356	CcSEcCtD
Tamoxifen—Vomiting—Ethinyl Estradiol—osteoporosis	4.35e-05	0.000351	CcSEcCtD
Tamoxifen—Diarrhoea—Pamidronate—osteoporosis	4.34e-05	0.00035	CcSEcCtD
Tamoxifen—Hyperhidrosis—Estradiol—osteoporosis	4.31e-05	0.000348	CcSEcCtD
Tamoxifen—Rash—Ethinyl Estradiol—osteoporosis	4.31e-05	0.000348	CcSEcCtD
Tamoxifen—Dermatitis—Ethinyl Estradiol—osteoporosis	4.31e-05	0.000348	CcSEcCtD
Tamoxifen—Headache—Ethinyl Estradiol—osteoporosis	4.29e-05	0.000346	CcSEcCtD
Tamoxifen—Hypersensitivity—Zoledronate—osteoporosis	4.27e-05	0.000344	CcSEcCtD
Tamoxifen—Vomiting—Risedronate—osteoporosis	4.24e-05	0.000342	CcSEcCtD
Tamoxifen—Rash—Risedronate—osteoporosis	4.21e-05	0.000339	CcSEcCtD
Tamoxifen—Dermatitis—Risedronate—osteoporosis	4.2e-05	0.000339	CcSEcCtD
Tamoxifen—Dizziness—Pamidronate—osteoporosis	4.19e-05	0.000338	CcSEcCtD
Tamoxifen—Headache—Risedronate—osteoporosis	4.18e-05	0.000337	CcSEcCtD
Tamoxifen—Asthenia—Zoledronate—osteoporosis	4.16e-05	0.000335	CcSEcCtD
Tamoxifen—Hypersensitivity—Conjugated Estrogens—osteoporosis	4.11e-05	0.000332	CcSEcCtD
Tamoxifen—Pruritus—Zoledronate—osteoporosis	4.1e-05	0.000331	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Estradiol—osteoporosis	4.07e-05	0.000328	CcSEcCtD
Tamoxifen—Nausea—Ethinyl Estradiol—osteoporosis	4.06e-05	0.000328	CcSEcCtD
Tamoxifen—Insomnia—Estradiol—osteoporosis	4.04e-05	0.000326	CcSEcCtD
Tamoxifen—Vomiting—Pamidronate—osteoporosis	4.03e-05	0.000325	CcSEcCtD
Tamoxifen—Paraesthesia—Estradiol—osteoporosis	4.01e-05	0.000323	CcSEcCtD
Tamoxifen—Asthenia—Conjugated Estrogens—osteoporosis	4e-05	0.000323	CcSEcCtD
Tamoxifen—Rash—Pamidronate—osteoporosis	4e-05	0.000323	CcSEcCtD
Tamoxifen—Dermatitis—Pamidronate—osteoporosis	3.99e-05	0.000322	CcSEcCtD
Tamoxifen—Dyspnoea—Estradiol—osteoporosis	3.98e-05	0.000321	CcSEcCtD
Tamoxifen—Headache—Pamidronate—osteoporosis	3.97e-05	0.000321	CcSEcCtD
Tamoxifen—Diarrhoea—Zoledronate—osteoporosis	3.96e-05	0.00032	CcSEcCtD
Tamoxifen—Nausea—Risedronate—osteoporosis	3.96e-05	0.00032	CcSEcCtD
Tamoxifen—Pruritus—Conjugated Estrogens—osteoporosis	3.95e-05	0.000318	CcSEcCtD
Tamoxifen—Dyspepsia—Estradiol—osteoporosis	3.93e-05	0.000317	CcSEcCtD
Tamoxifen—Decreased appetite—Estradiol—osteoporosis	3.88e-05	0.000313	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Estradiol—osteoporosis	3.85e-05	0.000311	CcSEcCtD
Tamoxifen—Fatigue—Estradiol—osteoporosis	3.85e-05	0.000311	CcSEcCtD
Tamoxifen—Dizziness—Zoledronate—osteoporosis	3.83e-05	0.000309	CcSEcCtD
Tamoxifen—Pain—Estradiol—osteoporosis	3.82e-05	0.000308	CcSEcCtD
Tamoxifen—Constipation—Estradiol—osteoporosis	3.82e-05	0.000308	CcSEcCtD
Tamoxifen—Diarrhoea—Conjugated Estrogens—osteoporosis	3.82e-05	0.000308	CcSEcCtD
Tamoxifen—Nausea—Pamidronate—osteoporosis	3.77e-05	0.000304	CcSEcCtD
Tamoxifen—Dizziness—Conjugated Estrogens—osteoporosis	3.69e-05	0.000298	CcSEcCtD
Tamoxifen—Vomiting—Zoledronate—osteoporosis	3.68e-05	0.000297	CcSEcCtD
Tamoxifen—Rash—Zoledronate—osteoporosis	3.65e-05	0.000295	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Estradiol—osteoporosis	3.65e-05	0.000295	CcSEcCtD
Tamoxifen—Dermatitis—Zoledronate—osteoporosis	3.65e-05	0.000294	CcSEcCtD
Tamoxifen—Headache—Zoledronate—osteoporosis	3.63e-05	0.000293	CcSEcCtD
Tamoxifen—Vomiting—Conjugated Estrogens—osteoporosis	3.55e-05	0.000286	CcSEcCtD
Tamoxifen—Urticaria—Estradiol—osteoporosis	3.55e-05	0.000286	CcSEcCtD
Tamoxifen—Abdominal pain—Estradiol—osteoporosis	3.53e-05	0.000285	CcSEcCtD
Tamoxifen—Rash—Conjugated Estrogens—osteoporosis	3.52e-05	0.000284	CcSEcCtD
Tamoxifen—Dermatitis—Conjugated Estrogens—osteoporosis	3.51e-05	0.000284	CcSEcCtD
Tamoxifen—Headache—Conjugated Estrogens—osteoporosis	3.49e-05	0.000282	CcSEcCtD
Tamoxifen—Nausea—Zoledronate—osteoporosis	3.44e-05	0.000278	CcSEcCtD
Tamoxifen—Nausea—Conjugated Estrogens—osteoporosis	3.31e-05	0.000267	CcSEcCtD
Tamoxifen—Hypersensitivity—Estradiol—osteoporosis	3.29e-05	0.000265	CcSEcCtD
Tamoxifen—Asthenia—Estradiol—osteoporosis	3.2e-05	0.000258	CcSEcCtD
Tamoxifen—Pruritus—Estradiol—osteoporosis	3.16e-05	0.000255	CcSEcCtD
Tamoxifen—Diarrhoea—Estradiol—osteoporosis	3.05e-05	0.000246	CcSEcCtD
Tamoxifen—Dizziness—Estradiol—osteoporosis	2.95e-05	0.000238	CcSEcCtD
Tamoxifen—Vomiting—Estradiol—osteoporosis	2.84e-05	0.000229	CcSEcCtD
Tamoxifen—Rash—Estradiol—osteoporosis	2.81e-05	0.000227	CcSEcCtD
Tamoxifen—Dermatitis—Estradiol—osteoporosis	2.81e-05	0.000227	CcSEcCtD
Tamoxifen—Headache—Estradiol—osteoporosis	2.8e-05	0.000226	CcSEcCtD
Tamoxifen—Nausea—Estradiol—osteoporosis	2.65e-05	0.000214	CcSEcCtD
Tamoxifen—CYP2D6—Metabolism—OXCT1—osteoporosis	6.35e-06	0.000113	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CA2—osteoporosis	6.35e-06	0.000113	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	6.35e-06	0.000113	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ATIC—osteoporosis	6.33e-06	0.000113	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PNP—osteoporosis	6.33e-06	0.000113	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—ENO1—osteoporosis	6.33e-06	0.000113	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	6.32e-06	0.000112	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—ADCY5—osteoporosis	6.31e-06	0.000112	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—TPI1—osteoporosis	6.31e-06	0.000112	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CA2—osteoporosis	6.3e-06	0.000112	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—OXCT1—osteoporosis	6.3e-06	0.000112	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—TPI1—osteoporosis	6.29e-06	0.000112	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—POMC—osteoporosis	6.29e-06	0.000112	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—WNT1—osteoporosis	6.29e-06	0.000112	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PSMA2—osteoporosis	6.29e-06	0.000112	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PSMA5—osteoporosis	6.29e-06	0.000112	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—GPX1—osteoporosis	6.29e-06	0.000112	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PSMA5—osteoporosis	6.23e-06	0.000111	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PSMA2—osteoporosis	6.23e-06	0.000111	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—MGLL—osteoporosis	6.19e-06	0.00011	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—MGLL—osteoporosis	6.14e-06	0.000109	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—FGA—osteoporosis	6.12e-06	0.000109	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—P4HB—osteoporosis	6.05e-06	0.000108	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—CYP27A1—osteoporosis	6.03e-06	0.000107	CbGpPWpGaD
Tamoxifen—CYP3A4—Biological oxidations—POMC—osteoporosis	5.97e-06	0.000106	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—TPI1—osteoporosis	5.95e-06	0.000106	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—GAPDH—osteoporosis	5.94e-06	0.000106	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—P4HB—osteoporosis	5.93e-06	0.000106	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—P4HB—osteoporosis	5.92e-06	0.000105	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—ACP5—osteoporosis	5.86e-06	0.000104	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—VDR—osteoporosis	5.86e-06	0.000104	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—GAPDH—osteoporosis	5.82e-06	0.000104	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—GAPDH—osteoporosis	5.81e-06	0.000103	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—MTHFR—osteoporosis	5.8e-06	0.000103	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—ENO1—osteoporosis	5.8e-06	0.000103	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	5.79e-06	0.000103	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—RAP1A—osteoporosis	5.79e-06	0.000103	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	5.79e-06	0.000103	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—IDH2—osteoporosis	5.72e-06	0.000102	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PSMA2—osteoporosis	5.71e-06	0.000102	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PSMA5—osteoporosis	5.71e-06	0.000102	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PTHLH—osteoporosis	5.69e-06	0.000101	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—BMP2—osteoporosis	5.69e-06	0.000101	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—RAP1A—osteoporosis	5.67e-06	0.000101	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—RAP1A—osteoporosis	5.66e-06	0.000101	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PKM—osteoporosis	5.63e-06	0.0001	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—FDPS—osteoporosis	5.63e-06	0.0001	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—CYP19A1—osteoporosis	5.61e-06	9.99e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—P4HB—osteoporosis	5.59e-06	9.96e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—IDH2—osteoporosis	5.59e-06	9.95e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—FGB—osteoporosis	5.57e-06	9.91e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—GAPDH—osteoporosis	5.49e-06	9.77e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—TPI1—osteoporosis	5.45e-06	9.71e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—OXCT1—osteoporosis	5.38e-06	9.58e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CA2—osteoporosis	5.38e-06	9.58e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CYP27A1—osteoporosis	5.38e-06	9.58e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PSMA5—osteoporosis	5.37e-06	9.57e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PSMA2—osteoporosis	5.37e-06	9.57e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—RAP1A—osteoporosis	5.35e-06	9.52e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GPD2—osteoporosis	5.34e-06	9.51e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PGLS—osteoporosis	5.34e-06	9.51e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—IDH2—osteoporosis	5.26e-06	9.37e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CYP27A1—osteoporosis	5.25e-06	9.35e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—MGLL—osteoporosis	5.24e-06	9.34e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ACP5—osteoporosis	5.23e-06	9.32e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—IDH2—osteoporosis	5.22e-06	9.29e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	5.17e-06	9.2e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	5.15e-06	9.18e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	5.14e-06	9.15e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—P4HB—osteoporosis	5.13e-06	9.13e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—ACP5—osteoporosis	5.11e-06	9.1e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—CYP19A1—osteoporosis	5.1e-06	9.09e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—CYP19A1—osteoporosis	5.06e-06	9.01e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—GAPDH—osteoporosis	5.03e-06	8.96e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CALCA—osteoporosis	5.01e-06	8.92e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CYP27A1—osteoporosis	4.95e-06	8.81e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	4.95e-06	8.81e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CYP27A1—osteoporosis	4.91e-06	8.74e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—RAP1A—osteoporosis	4.9e-06	8.73e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ATIC—osteoporosis	4.88e-06	8.7e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PNP—osteoporosis	4.88e-06	8.7e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—TPI1—osteoporosis	4.87e-06	8.66e-05	CbGpPWpGaD
Tamoxifen—ESR1—Generic Transcription Pathway—MYC—osteoporosis	4.84e-06	8.62e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ACP5—osteoporosis	4.81e-06	8.57e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.81e-06	8.57e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	4.8e-06	8.55e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ACP5—osteoporosis	4.77e-06	8.5e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—ADCY5—osteoporosis	4.76e-06	8.47e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—TPI1—osteoporosis	4.75e-06	8.46e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—GPX1—osteoporosis	4.74e-06	8.44e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.71e-06	8.39e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—ENO1—osteoporosis	4.68e-06	8.33e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.66e-06	8.3e-05	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—POMC—osteoporosis	4.64e-06	8.26e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—CYP19A1—osteoporosis	4.64e-06	8.25e-05	CbGpPWpGaD
Tamoxifen—ESR2—Gene Expression—MYC—osteoporosis	4.62e-06	8.23e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PSMA2—osteoporosis	4.61e-06	8.21e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PSMA5—osteoporosis	4.61e-06	8.21e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—ADCY5—osteoporosis	4.58e-06	8.16e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—ENO1—osteoporosis	4.58e-06	8.16e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—P4HB—osteoporosis	4.58e-06	8.15e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—ENO1—osteoporosis	4.57e-06	8.14e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—GPX1—osteoporosis	4.57e-06	8.13e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—KL—osteoporosis	4.55e-06	8.1e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PSMA2—osteoporosis	4.52e-06	8.04e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PSMA5—osteoporosis	4.52e-06	8.04e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PSMA2—osteoporosis	4.51e-06	8.02e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PSMA5—osteoporosis	4.51e-06	8.02e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GAPDH—osteoporosis	4.49e-06	8e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—TPI1—osteoporosis	4.48e-06	7.97e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—P4HB—osteoporosis	4.47e-06	7.95e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—IDH2—osteoporosis	4.46e-06	7.94e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—TPI1—osteoporosis	4.44e-06	7.9e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GAPDH—osteoporosis	4.38e-06	7.8e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—MTHFR—osteoporosis	4.38e-06	7.79e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—RAP1A—osteoporosis	4.37e-06	7.79e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—ENO1—osteoporosis	4.32e-06	7.69e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.27e-06	7.61e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—RAP1A—osteoporosis	4.27e-06	7.6e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PSMA2—osteoporosis	4.26e-06	7.58e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PSMA5—osteoporosis	4.26e-06	7.58e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—MTHFR—osteoporosis	4.22e-06	7.5e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—P4HB—osteoporosis	4.21e-06	7.49e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CYP27A1—osteoporosis	4.19e-06	7.47e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—P4HB—osteoporosis	4.17e-06	7.43e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—ADCY5—osteoporosis	4.17e-06	7.42e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—GPX1—osteoporosis	4.16e-06	7.4e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CA2—osteoporosis	4.15e-06	7.4e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—OXCT1—osteoporosis	4.15e-06	7.4e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—ADCY5—osteoporosis	4.13e-06	7.36e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GAPDH—osteoporosis	4.13e-06	7.35e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—GPX1—osteoporosis	4.12e-06	7.33e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GAPDH—osteoporosis	4.1e-06	7.29e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ACP5—osteoporosis	4.08e-06	7.26e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—MGLL—osteoporosis	4.05e-06	7.21e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.03e-06	7.17e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—RAP1A—osteoporosis	4.02e-06	7.16e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—RAP1A—osteoporosis	3.99e-06	7.1e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—ENO1—osteoporosis	3.96e-06	7.05e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PSMA2—osteoporosis	3.9e-06	6.95e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PSMA5—osteoporosis	3.9e-06	6.95e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—MTHFR—osteoporosis	3.83e-06	6.83e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.81e-06	6.79e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—MTHFR—osteoporosis	3.8e-06	6.77e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—TPI1—osteoporosis	3.79e-06	6.75e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—ADCY5—osteoporosis	3.79e-06	6.74e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—GPX1—osteoporosis	3.78e-06	6.72e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—CYP19A1—osteoporosis	3.74e-06	6.66e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—CYP19A1—osteoporosis	3.66e-06	6.52e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—CYP19A1—osteoporosis	3.66e-06	6.51e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—P4HB—osteoporosis	3.57e-06	6.35e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—ADCY5—osteoporosis	3.56e-06	6.34e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ENO1—osteoporosis	3.54e-06	6.3e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—POMC—osteoporosis	3.5e-06	6.23e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GAPDH—osteoporosis	3.5e-06	6.23e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PSMA2—osteoporosis	3.48e-06	6.2e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PSMA5—osteoporosis	3.48e-06	6.2e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—MTHFR—osteoporosis	3.48e-06	6.2e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.48e-06	6.19e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—CYP19A1—osteoporosis	3.45e-06	6.15e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—ENO1—osteoporosis	3.45e-06	6.14e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—SPP1—osteoporosis	3.45e-06	6.14e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—IDH2—osteoporosis	3.44e-06	6.13e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—RAP1A—osteoporosis	3.41e-06	6.07e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PSMA2—osteoporosis	3.4e-06	6.05e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PSMA5—osteoporosis	3.4e-06	6.05e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—POMC—osteoporosis	3.37e-06	6e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ENO1—osteoporosis	3.25e-06	5.79e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYP27A1—osteoporosis	3.24e-06	5.76e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ENO1—osteoporosis	3.22e-06	5.74e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PSMA2—osteoporosis	3.2e-06	5.71e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PSMA5—osteoporosis	3.2e-06	5.71e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PSMA2—osteoporosis	3.18e-06	5.66e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PSMA5—osteoporosis	3.18e-06	5.66e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—CYP19A1—osteoporosis	3.17e-06	5.64e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ACP5—osteoporosis	3.15e-06	5.6e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IRS2—osteoporosis	3.12e-06	5.55e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—POMC—osteoporosis	3.07e-06	5.46e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—ADCY5—osteoporosis	3.06e-06	5.44e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—LEP—osteoporosis	3.05e-06	5.43e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—GPX1—osteoporosis	3.05e-06	5.42e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—POMC—osteoporosis	3.04e-06	5.41e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—ADCY5—osteoporosis	2.99e-06	5.33e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—ADCY5—osteoporosis	2.99e-06	5.32e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—GPX1—osteoporosis	2.98e-06	5.31e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—GPX1—osteoporosis	2.98e-06	5.3e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.97e-06	5.29e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—TPI1—osteoporosis	2.93e-06	5.21e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CYP19A1—osteoporosis	2.83e-06	5.03e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—ADCY5—osteoporosis	2.82e-06	5.03e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—GPX1—osteoporosis	2.81e-06	5.01e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—MTHFR—osteoporosis	2.81e-06	5e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—POMC—osteoporosis	2.79e-06	4.96e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CYP19A1—osteoporosis	2.76e-06	4.91e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ENO1—osteoporosis	2.76e-06	4.91e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—MTHFR—osteoporosis	2.75e-06	4.9e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—P4HB—osteoporosis	2.75e-06	4.9e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—MTHFR—osteoporosis	2.75e-06	4.89e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IRS1—osteoporosis	2.72e-06	4.85e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PSMA5—osteoporosis	2.71e-06	4.83e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PSMA2—osteoporosis	2.71e-06	4.83e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GAPDH—osteoporosis	2.7e-06	4.81e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—RAP1A—osteoporosis	2.63e-06	4.68e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—POMC—osteoporosis	2.62e-06	4.67e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CYP19A1—osteoporosis	2.6e-06	4.63e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—MTHFR—osteoporosis	2.6e-06	4.62e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—ADCY5—osteoporosis	2.59e-06	4.61e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—GPX1—osteoporosis	2.58e-06	4.59e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CYP19A1—osteoporosis	2.58e-06	4.59e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IL6R—osteoporosis	2.56e-06	4.55e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IGF1—osteoporosis	2.52e-06	4.49e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—MTHFR—osteoporosis	2.38e-06	4.24e-05	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—MYC—osteoporosis	2.33e-06	4.15e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ADCY5—osteoporosis	2.31e-06	4.11e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GPX1—osteoporosis	2.3e-06	4.1e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—ADCY5—osteoporosis	2.25e-06	4.01e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—POMC—osteoporosis	2.25e-06	4e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GPX1—osteoporosis	2.25e-06	4e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CYP19A1—osteoporosis	2.2e-06	3.92e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—POMC—osteoporosis	2.2e-06	3.92e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—POMC—osteoporosis	2.2e-06	3.91e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ENO1—osteoporosis	2.13e-06	3.79e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ADCY5—osteoporosis	2.12e-06	3.78e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—MTHFR—osteoporosis	2.12e-06	3.78e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GPX1—osteoporosis	2.12e-06	3.77e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ADCY5—osteoporosis	2.11e-06	3.75e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GPX1—osteoporosis	2.1e-06	3.74e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PSMA5—osteoporosis	2.1e-06	3.73e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PSMA2—osteoporosis	2.1e-06	3.73e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—POMC—osteoporosis	2.08e-06	3.7e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—MTHFR—osteoporosis	2.07e-06	3.69e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—MTHFR—osteoporosis	1.95e-06	3.48e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—MTHFR—osteoporosis	1.94e-06	3.45e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—POMC—osteoporosis	1.9e-06	3.39e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ADCY5—osteoporosis	1.8e-06	3.2e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GPX1—osteoporosis	1.79e-06	3.19e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYP19A1—osteoporosis	1.7e-06	3.03e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—POMC—osteoporosis	1.7e-06	3.02e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—POMC—osteoporosis	1.66e-06	2.95e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—MTHFR—osteoporosis	1.66e-06	2.95e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—POMC—osteoporosis	1.56e-06	2.78e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—POMC—osteoporosis	1.55e-06	2.76e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MYC—osteoporosis	1.51e-06	2.7e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TGFB1—osteoporosis	1.51e-06	2.69e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ADCY5—osteoporosis	1.39e-06	2.47e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GPX1—osteoporosis	1.38e-06	2.46e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—POMC—osteoporosis	1.32e-06	2.36e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—MTHFR—osteoporosis	1.28e-06	2.27e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IL6—osteoporosis	1.14e-06	2.03e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—POMC—osteoporosis	1.02e-06	1.82e-05	CbGpPWpGaD
